Po Wang
Psychiatry · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 31 years
- Graduated 1995
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Po Wang’s office at (650) 723-4000 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$56,594
Medicare paid this office $56,594 for 40 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 37 | $32,288 | $117 |
| Psychotherapy with evaluation and management visit, 30 minutes | 39 | $17,941 | $64 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 32 | $1,528 | $15 |
Who their Medicare patients are
40 Original Medicare patients in 2024. Average age 69 · Women 68% · Health risk score 1.22. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 55% · Depression 28%.
The office billed $241,851, Medicare allowed $73,889 and paid $56,594; for 691 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 40 | 691 | 69 | 1.22 | $241,851 | $56,594 |
| 2023 | 36 | 678 | 71 | 1.09 | $251,648 | $49,800 |
| 2022 | 29 | 589 | 70 | 0.95 | $220,015 | $40,662 |
| 2021 | 26 | 307 | 67 | 1.03 | $110,545 | $20,397 |
| 2020 | 33 | 530 | 62 | 1.10 | $194,947 | $33,457 |
| 2019 | 38 | 408 | 63 | 1.20 | $127,753 | $28,571 |
| 2018 | 42 | 350 | 62 | 1.46 | $36,196 | $21,640 |
| 2017 | 30 | 316 | 59 | 1.39 | $39,914 | $18,989 |
| 2016 | 38 | 432 | 58 | 1.47 | $62,926 | $25,997 |
| 2015 | 43 | 456 | 58 | 1.39 | $64,511 | $28,061 |
| 2014 | 53 | 489 | 56 | 1.28 | $77,281 | $31,156 |
| 2013 | 43 | 484 | 58 | 1.00 | $76,198 | $22,060 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 26 | $25,183 | $120 |
| Psychotherapy with evaluation and management visit, 30 minutes | 29 | $14,286 | $63 |
| Telehealth originating site facility fee | 32 | $4,490 | $22 |
2022: 4 services
| Return visit (30+ min) | 27 | $20,974 | $118 |
| Psychotherapy with evaluation and management visit, 30 minutes | 26 | $12,027 | $62 |
| Telehealth originating site facility fee | 29 | $4,207 | $22 |
| Long return visit (40+ min) | 11 | $2,971 | $156 |
2021: 3 services
| Return visit (30+ min) | 20 | $10,854 | $117 |
| Psychotherapy with evaluation and management visit, 30 minutes | 21 | $5,562 | $59 |
| Telehealth originating site facility fee | 26 | $2,162 | $21 |
2020: 3 services
| Return visit (30+ min) | 28 | $15,028 | $98 |
| Psychotherapy with evaluation and management visit, 30 minutes | 27 | $9,936 | $61 |
| Telehealth originating site facility fee | 27 | $3,226 | $21 |
2019: 4 services
| Return visit (30+ min) | 22 | $9,100 | $103 |
| Psychotherapy with evaluation and management visit, 30 minutes | 23 | $5,786 | $62 |
| Return visit (30+ min) | 22 | $5,442 | $63 |
| Psychotherapy with evaluation and management visit, 30 minutes | 25 | $4,396 | $49 |
2018: 2 services
| Return visit (30+ min) | 27 | $10,257 | $67 |
| Psychotherapy with evaluation and management visit, 30 minutes | 30 | $8,342 | $53 |
2017: 2 services
| Return visit (30+ min) | 22 | $9,876 | $65 |
| Psychotherapy with evaluation and management visit, 30 minutes | 25 | $8,188 | $54 |
2016: 2 services
| Return visit (30+ min) | 25 | $12,355 | $66 |
| Psychotherapy with evaluation and management visit, 30 minutes | 28 | $9,006 | $53 |
2015: 2 services
| Return visit (30+ min) | 25 | $13,471 | $67 |
| Psychotherapy with evaluation and management visit, 30 minutes | 27 | $10,709 | $55 |
2014: 2 services
| Return visit (30+ min) | 24 | $12,769 | $66 |
| Psychotherapy with evaluation and management visit, 30 minutes | 27 | $9,603 | $55 |
2013: 2 services
| Return visit (30+ min) | 22 | $10,990 | $52 |
| Psychotherapy with evaluation and management visit, 30 minutes | 28 | $5,381 | $28 |
Drugs they prescribed that Part D paid
$114,679
Pharmacies billed $114,679 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 840) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
775 generic and 65 brand-name prescriptions · $114,679 in drug cost · 223 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vraylar | 20 | $34,561 | $1,728 |
| Belsomra | 24 | $10,046 | $419 |
| Fetzima | 11 | $6,260 | $569 |
| Lurasidone | 50 | $2,407 | $48 |
| Quetiapine | 64 | $1,179 | $18 |
See all 27 drugs
| Vraylar | 20 | $34,561 | $1,728 |
| Belsomra | 24 | $10,046 | $419 |
| Fetzima | 11 | $6,260 | $569 |
| Lurasidone | 50 | $2,407 | $48 |
| Quetiapine | 64 | $1,179 | $18 |
| Duloxetine | 45 | $1,145 | $25 |
| Modafinil | 13 | $1,142 | $88 |
| Aripiprazole | 40 | $913 | $23 |
| Lamotrigine | 64 | $848 | $13 |
| Gabapentin | 40 | $828 | $21 |
| Bupropion Xl | 29 | $726 | $25 |
| Divalproex | 13 | $570 | $44 |
| Escitalopram | 18 | $483 | $27 |
| Mirtazapine | 13 | $443 | $34 |
| Trazodone | 24 | $363 | $15 |
| Propranolol | 13 | $306 | $24 |
| Zolpidem | 51 | $296 | $6 |
| Risperidone | 24 | $220 | $9 |
| Venlafaxine Hcl Er | 24 | $211 | $9 |
| Olanzapine | 19 | $165 | $9 |
| Pramipexole Dihydrochloride | 16 | $159 | $10 |
| Ziprasidone | 11 | $134 | $12 |
| Lorazepam | 24 | $124 | $5 |
| Hydroxyzine | 15 | $122 | $8 |
| Clonazepam | 45 | $114 | $3 |
| Buspirone | 12 | $95 | $8 |
| Alprazolam | 14 | $8 | $1 |
Year by year
| 2024 | 840 | 40 | 0% (0) | 8% | $114,679 |
| 2023 | 567 | 31 | 0% (0) | 7% | $53,602 |
| 2022 | 447 | 24 | 0% (0) | 11% | $90,173 |
| 2021 | 296 | 23 | 0% (0) | 4% | $22,863 |
| 2020 | 343 | 25 | 0% (0) | 4% | $36,176 |
| 2019 | 423 | 25 | 0% (0) | 7% | $42,568 |
| 2018 | 429 | 25 | 0% (0) | 10% | $45,677 |
| 2017 | 456 | 29 | 0% (0) | 7% | $26,363 |
| 2016 | 568 | 31 | 0% (0) | 9% | $27,776 |
| 2015 | 388 | 29 | None | 9% | $28,545 |
| 2014 | 478 | 34 | 0% (0) | 11% | $34,714 |
| 2013 | 415 | 29 | 0% (0) | 15% | $42,409 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Vraylar | 14 | $17,723 | $1,266 |
| Belsomra | 19 | $8,611 | $453 |
| Quetiapine | 49 | $1,833 | $37 |
| Lamotrigine | 39 | $1,552 | $40 |
| Lurasidone | 28 | $1,248 | $45 |
| Aripiprazole | 24 | $972 | $41 |
| Duloxetine | 23 | $915 | $40 |
| Divalproex | 12 | $864 | $72 |
| Olanzapine | 16 | $709 | $44 |
| Bupropion Xl | 15 | $588 | $39 |
| Risperidone | 19 | $446 | $23 |
| Escitalopram | 14 | $409 | $29 |
| Clonazepam | 43 | $393 | $9 |
| Mirtazapine | 17 | $355 | $21 |
| Zolpidem | 51 | $272 | $5 |
| Venlafaxine Hcl Er | 22 | $257 | $12 |
| Trazodone | 21 | $255 | $12 |
| Lorazepam | 24 | $143 | $6 |
| Hydroxyzine | 11 | $111 | $10 |
| Alprazolam | 12 | $46 | $4 |
2022: 14 drugs
| Belsomra | 16 | $6,909 | $432 |
| Duloxetine | 26 | $1,151 | $44 |
| Quetiapine | 33 | $991 | $30 |
| Bupropion Xl | 15 | $938 | $63 |
| Aripiprazole | 26 | $917 | $35 |
| Lamotrigine | 29 | $914 | $32 |
| Clonazepam | 46 | $456 | $10 |
| Zolpidem | 51 | $306 | $6 |
| Olanzapine | 14 | $282 | $20 |
| Trazodone | 11 | $180 | $16 |
| Venlafaxine Hcl Er | 11 | $132 | $12 |
| Sertraline | 12 | $107 | $9 |
| Lorazepam | 21 | $106 | $5 |
| Alprazolam | 14 | $46 | $3 |
2021: 9 drugs
| Duloxetine | 38 | $1,148 | $30 |
| Quetiapine | 26 | $1,038 | $40 |
| Aripiprazole | 24 | $729 | $30 |
| Lamotrigine | 24 | $535 | $22 |
| Zolpidem Tartrate Er | 11 | $390 | $35 |
| Zolpidem | 18 | $163 | $9 |
| Risperidone | 11 | $159 | $14 |
| Lorazepam | 16 | $142 | $9 |
| Clonazepam | 16 | $57 | $4 |
2020: 9 drugs
| Pramipexole Dihydrochloride | 30 | $1,212 | $40 |
| Duloxetine | 21 | $830 | $40 |
| Quetiapine | 40 | $794 | $20 |
| Bupropion Xl | 23 | $665 | $29 |
| Aripiprazole | 19 | $593 | $31 |
| Lamotrigine | 48 | $587 | $12 |
| Clonazepam | 17 | $91 | $5 |
| Risperidone | 13 | $81 | $6 |
| Alprazolam | 15 | $32 | $2 |
2019: 12 drugs
| Latuda | 13 | $28,772 | $2,213 |
| Quetiapine | 60 | $1,423 | $24 |
| Bupropion Xl | 25 | $1,096 | $44 |
| Duloxetine | 17 | $963 | $57 |
| Mirtazapine | 19 | $804 | $42 |
| Aripiprazole | 19 | $693 | $36 |
| Lamotrigine | 61 | $503 | $8 |
| Gabapentin | 31 | $450 | $15 |
| Divalproex | 20 | $248 | $12 |
| Trazodone | 15 | $164 | $11 |
| Risperidone | 21 | $79 | $4 |
| Alprazolam | 13 | $47 | $4 |
2018: 15 drugs
| Latuda | 20 | $33,188 | $1,659 |
| Bupropion Xl | 23 | $955 | $42 |
| Quetiapine | 74 | $769 | $10 |
| Mirtazapine | 28 | $640 | $23 |
| Lamotrigine | 58 | $500 | $9 |
| Duloxetine | 11 | $372 | $34 |
| Gabapentin | 14 | $360 | $26 |
| Aripiprazole | 12 | $259 | $22 |
| Lithium Carbonate Er | 12 | $239 | $20 |
| Risperidone | 31 | $195 | $6 |
| Lithium Carbonate | 11 | $193 | $18 |
| Alprazolam | 14 | $94 | $7 |
| Trazodone | 15 | $86 | $6 |
| Clonazepam | 17 | $79 | $5 |
| Sertraline | 12 | $20 | $2 |
2017: 13 drugs
| Ziprasidone | 12 | $2,266 | $189 |
| Aripiprazole | 12 | $916 | $76 |
| Lamotrigine | 68 | $877 | $13 |
| Quetiapine | 63 | $634 | $10 |
| Venlafaxine Hcl Er | 16 | $605 | $38 |
| Mirtazapine | 35 | $596 | $17 |
| Lithium Carbonate | 24 | $256 | $11 |
| Clonazepam | 35 | $193 | $6 |
| Risperidone | 24 | $153 | $6 |
| Divalproex | 21 | $142 | $7 |
| Buspirone | 11 | $134 | $12 |
| Trazodone | 11 | $79 | $7 |
| Sertraline | 14 | $31 | $2 |
2016: 18 drugs
| Ziprasidone | 21 | $3,115 | $148 |
| Quetiapine | 66 | $1,830 | $28 |
| Lamotrigine | 74 | $1,318 | $18 |
| Divalproex Sodium Er | 11 | $857 | $78 |
| Lithium Carbonate Er | 25 | $646 | $26 |
| Bupropion Xl | 12 | $503 | $42 |
| Clozapine | 13 | $398 | $31 |
| Mirtazapine | 21 | $384 | $18 |
| Propranolol | 17 | $296 | $17 |
| Risperidone | 34 | $225 | $7 |
| Lithium Carbonate | 27 | $192 | $7 |
| Divalproex | 25 | $174 | $7 |
| Sertraline | 13 | $152 | $12 |
| Clonazepam | 35 | $149 | $4 |
| Lorazepam | 15 | $100 | $7 |
| Escitalopram | 18 | $92 | $5 |
| Citalopram Hbr | 15 | $81 | $5 |
| Diazepam | 12 | $81 | $7 |
2015: 11 drugs
| Ziprasidone | 29 | $4,440 | $153 |
| Lamotrigine | 66 | $1,102 | $17 |
| Clozapine | 13 | $1,034 | $80 |
| Quetiapine | 24 | $864 | $36 |
| Lithium Carbonate Er | 20 | $489 | $24 |
| Clonazepam | 33 | $242 | $7 |
| Escitalopram | 15 | $190 | $13 |
| Buspirone | 12 | $185 | $15 |
| Lithium Carbonate | 24 | $162 | $7 |
| Sertraline | 14 | $137 | $10 |
| Risperidone | 17 | $125 | $7 |
2014: 14 drugs
| Abilify | 11 | $8,669 | $788 |
| Ziprasidone | 29 | $4,260 | $147 |
| Quetiapine | 41 | $2,433 | $59 |
| Lamotrigine | 68 | $1,503 | $22 |
| Clozapine | 15 | $634 | $42 |
| Bupropion Xl | 13 | $598 | $46 |
| Lithium Carbonate Er | 28 | $590 | $21 |
| Risperidone | 29 | $458 | $16 |
| Clonazepam | 31 | $386 | $12 |
| Lithium Carbonate | 30 | $350 | $12 |
| Fluoxetine | 15 | $230 | $15 |
| Zolpidem | 21 | $221 | $11 |
| Lorazepam | 16 | $128 | $8 |
| Escitalopram | 14 | $125 | $9 |
2013: 14 drugs
| Abilify | 13 | $8,676 | $667 |
| Latuda | 12 | $7,018 | $585 |
| Quetiapine | 57 | $6,547 | $115 |
| Ziprasidone | 23 | $4,874 | $212 |
| Divalproex Sodium Er | 14 | $3,419 | $244 |
| Viibryd | 12 | $1,826 | $152 |
| Risperidone | 17 | $1,499 | $88 |
| Lamotrigine | 59 | $1,408 | $24 |
| Escitalopram | 14 | $1,279 | $91 |
| Bupropion Xl | 13 | $883 | $68 |
| Lithium Carbonate | 28 | $650 | $23 |
| Clonazepam | 39 | $445 | $11 |
| Ropinirole | 11 | $201 | $18 |
| Zolpidem | 14 | $104 | $7 |
Money from drug and device companies
$4,230 in 2023
A payment is not proof that care is biased.
| Genentech | None | $4,230 | 2 payments
|
See all 2 published payments
| Genentech | Consulting · 2023-08-21 | None | $2,115 |
| Genentech | Consulting · 2023-02-20 | None | $2,115 |
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Merck Sharp & Dohme LLC · A Double-Blind, Randomized, Placebo-Controlled Trial of Adjunctive Suvorexant for Treatment-Resistant Insomnia in Patients With Bipolar Disorder · 2022 | Their institution | $115,465 |
| Merck Sharp & Dohme Corporation · A Double-Blind, Randomized, Placebo-Controlled Trial of Adjunctive Suvorexant for Treatment-Resistant Insomnia in Patients With Bipolar Disorder · 2021 | Their institution | $76,779 |
| Merck Sharp & Dohme Corporation · A Double-Blind, Randomized, Placebo-Controlled Trial of Adjunctive Suvorexant for Treatment-Resistant Insomnia in Patients With Bipolar Disorder · 2020 | Their institution | $11,058 |
| Merck Sharp & Dohme Corporation · A Double-Blind, Randomized, Placebo-Controlled Trial of Adjunctive Suvorexant for Treatment-Resistant Insomnia in Patients With Bipolar Disorder · 2019 | Their institution | $697 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1982748018
- Licence
- CA A060666
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-02-20
- NPI last updated
- 2024-04-28
- NPI record certified
- 2024-04-28
This is when the NPI record was last certified, not a medical board exam.